Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus

John M. Galla, Stephen J. Nicholls

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Accelerated progression of coronary atherosclerosis underlies the heightened cardiovascular risk observed in diabetic patients. As the worldwide prevalence of diabetes escalates in association with the incidence of abdominal obesity, the global burden of cardiovascular disease will continue to rise. Therapeutic strategies that have had the greatest cardiovascular benefit in diabetes have focused on lowering LDL-cholesterol and blood pressure, rather than glucose-lowering specifically. More recently, arterial wall imaging has helped characterize the natural history of coronary atherosclerosis in diabetes, the impact of associated risk factors and the influence of medical therapies.

LanguageEnglish
Pages85-93
Number of pages9
JournalExpert Review of Cardiovascular Therapy
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 2009
Externally publishedYes

Keywords

  • Atherosclerosis
  • Cardiovascular prevention
  • Diabetes
  • Imaging
  • Risk factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

@article{07529765b4f84eaf8406288384afe783,
title = "Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus",
abstract = "Accelerated progression of coronary atherosclerosis underlies the heightened cardiovascular risk observed in diabetic patients. As the worldwide prevalence of diabetes escalates in association with the incidence of abdominal obesity, the global burden of cardiovascular disease will continue to rise. Therapeutic strategies that have had the greatest cardiovascular benefit in diabetes have focused on lowering LDL-cholesterol and blood pressure, rather than glucose-lowering specifically. More recently, arterial wall imaging has helped characterize the natural history of coronary atherosclerosis in diabetes, the impact of associated risk factors and the influence of medical therapies.",
keywords = "Atherosclerosis, Cardiovascular prevention, Diabetes, Imaging, Risk factor",
author = "Galla, {John M.} and Nicholls, {Stephen J.}",
year = "2009",
month = "1",
doi = "10.1586/14779072.7.1.85",
language = "English",
volume = "7",
pages = "85--93",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "1",

}

Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus. / Galla, John M.; Nicholls, Stephen J.

In: Expert Review of Cardiovascular Therapy, Vol. 7, No. 1, 01.2009, p. 85-93.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus

AU - Galla, John M.

AU - Nicholls, Stephen J.

PY - 2009/1

Y1 - 2009/1

N2 - Accelerated progression of coronary atherosclerosis underlies the heightened cardiovascular risk observed in diabetic patients. As the worldwide prevalence of diabetes escalates in association with the incidence of abdominal obesity, the global burden of cardiovascular disease will continue to rise. Therapeutic strategies that have had the greatest cardiovascular benefit in diabetes have focused on lowering LDL-cholesterol and blood pressure, rather than glucose-lowering specifically. More recently, arterial wall imaging has helped characterize the natural history of coronary atherosclerosis in diabetes, the impact of associated risk factors and the influence of medical therapies.

AB - Accelerated progression of coronary atherosclerosis underlies the heightened cardiovascular risk observed in diabetic patients. As the worldwide prevalence of diabetes escalates in association with the incidence of abdominal obesity, the global burden of cardiovascular disease will continue to rise. Therapeutic strategies that have had the greatest cardiovascular benefit in diabetes have focused on lowering LDL-cholesterol and blood pressure, rather than glucose-lowering specifically. More recently, arterial wall imaging has helped characterize the natural history of coronary atherosclerosis in diabetes, the impact of associated risk factors and the influence of medical therapies.

KW - Atherosclerosis

KW - Cardiovascular prevention

KW - Diabetes

KW - Imaging

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=60549100872&partnerID=8YFLogxK

U2 - 10.1586/14779072.7.1.85

DO - 10.1586/14779072.7.1.85

M3 - Review article

VL - 7

SP - 85

EP - 93

JO - Expert Review of Cardiovascular Therapy

T2 - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 1

ER -